Call Us:+91 99303 79639
 
Unimax is exhibiting at CPHI Barcelona 2023 (Hall 6 , Booth Number - IP39). Unimax has received CEP Registration Number 2023-189 for API 'Erythromycin Base'
Pharmaceutical technician in sterile environment at pharmacy industry
  • 3 manufacturing facilities compliant with global regulatory standards catering requirement from few gm to MT
  • Unimax currently operates three manufacturing sites in Tarapur, India
  • All three facilities are built as per ICH-GMP guidelines
  • Unimax is commercial scale manufacturer of low and high dosage APIs.
  • Total Production Capacity of 300MT and manufactures API in therapeutic category of Antibiotics, GlucoCortico Steroids,etc
  • The pilot plants at Unimax is capable of handling high and low dose products
  • Final product crystallisation & powder processing activities like Drying, Milling, Sifting, Blending are carried out in ISO 8 compliant clean room areas.
  • Unimax has in-house facility of compaction and micronization to support customer needs of finished dosage.
  • Multipurpose manufacturing facility with capacity to manufacture small, medium and large volume products
Manufacturing Plant Gallery